Recent research has shown that 0.3% of unselected leiomyomas were reclassified as IMTs based on positive anaplastic lymphoma kinase (ALK) immunohistochemistry (IHC) (4), even though routine ALK screening for the diagnosis of leiomyomas is not currently recommended. Here, ALK is linked to leiomyoma.